Cargando…

Asthma-COPD Overlap Syndrome: What We Know and What We Don't

Approximately one in four patients with chronic obstructive pulmonary disease (COPD) have asthmatic features consisting of wheezing, airway hyper-responsiveness or atopy. The Global initiative for Asthma/Globalinitiative for chronic Obstructive Lung Disease committee recently labelled these patients...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sin, Don D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256349/ https://www.ncbi.nlm.nih.gov/pubmed/28119742 http://dx.doi.org/10.4046/trd.2017.80.1.11

Ejemplares similares

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Commentary: When we don't know what we don't know
por: Paone, Gaetano
Publicado: (2020)

From CERN to Entrepreneurship: we don't know what we don't know
por: Zucchelli, Piero
Publicado: (2017)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Zika: what we know and don't know
por: Diop, Doudou, et al.
Publicado: (2016)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

COVID-19 in Children: What We Know and What We Don’t Know?
por: Jat, Kana Ram
Publicado: (2021)

Neurocognitive functioning in bipolar disorder: What we know and what we don’t
por: Keramatian, Kamyar, et al.
Publicado: (2022)

ECLS-associated infections in adults: what we know and what we don’t yet know
por: Abrams, Darryl, et al.
Publicado: (2019)

The Etiology of Femoroacetabular Impingement: What We Know and What We Don’t
por: Chaudhry, Harman, et al.
Publicado: (2014)

The Novel Coronavirus Outbreak: What We Know and What We Don’t
Publicado: (2020)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
por: Kerensky, Todd, et al.
Publicado: (2017)

Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know
por: Terhorst-Molawi, Dorothea, et al.
Publicado: (2023)

COVID-19 and the kidney: what we think we know so far and what we don’t
por: Farouk, Samira S., et al.
Publicado: (2020)

Digital Hazards for Feeding and Eating: What We Know and What We Don't
por: Ioannidis, Konstantinos, et al.
Publicado: (2021)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

Online Porn Addiction: What We Know and What We Don’t—A Systematic Review
por: de Alarcón, Rubén, et al.
Publicado: (2019)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

Immune responses to Tilapia lake virus infection: what we know and what we don’t know
por: Kembou-Ringert, Japhette E., et al.
Publicado: (2023)

Vasodilators in the treatment of acute heart failure: what we know, what we don’t
por: Metra, Marco, et al.
Publicado: (2008)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
por: Ohyama, Yukako, et al.
Publicado: (2021)

Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management
por: Shafiei, Mostafa, et al.
Publicado: (2012)

Donor and Donation Images (DDI)—A Scoping Review of What We Know and What We Don’t
por: Laskowski, Nora M., et al.
Publicado: (2023)

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
por: Lingor, Paul, et al.
Publicado: (2022)

Low Carbohydrate and Low-Fat Diets: What We Don’t Know and Why We Should Know It
por: Seid, Heather, et al.
Publicado: (2019)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Acute Myocardial Response to Stretch: What We (don't) Know
por: Neves, João S., et al.
Publicado: (2016)

Foot‐and‐Mouth Disease Impact on Smallholders ‐ What Do We Know, What Don't We Know and How Can We Find Out More?
por: Knight‐Jones, T. J. D., et al.
Publicado: (2016)

What we know and what we don't know about cancer risks associated with radiation doses from radiological imaging
por: Brenner, D J
Publicado: (2014)

Commentary: Acute Myocardial Response to Stretch: What We (don't) Know
por: Vahidi, Reza, et al.
Publicado: (2017)

Chemicals and children's environment: what we don't know about risks.
por: Goldman, L R
Publicado: (1998)

The Effects of Non-Nutritive Sweetener Consumption in the Pediatric Populations: What We Know, What We Don’t, and What We Need to Learn
por: Shum, Betty, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dsnfif3d4qfkvhcj0q8l3vouho